Psychologists in Daphne, AL Accepting Medicare

4 Psychologists found. Showing 1 - 4

Alicia Perry, PH.D. Psychologist - Clinical Child & Adolescent Medicare: Not Enrolled in Medicare Practice Location: 28311 N Main St, Ste 100, Daphne, AL 36526 Phone: 251-625-6233    Fax: 251-625-1482

Mr. Erik Paul Goldschmidt, PH.D. Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 25833 State Highway 181 Ste C, Daphne, AL 36526 Phone: 251-861-1313

Katherine Penry Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1203 Us Highway 98, Unit 3b, Daphne, AL 36526 Phone: 504-780-1702    Fax: 504-780-1705

Elizabethann Moore, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 27625 Us Highway 98, Building A, Daphne, AL 36526 Phone: 251-626-7959    Fax: 251-626-6122

News Archive

Researchers reveal how overloading of protein transport mechanisms triggers cellular defects

Researchers at Okayama University report in Scientific Reports how the overloading of protein transport mechanisms affects cell functioning. Over-expression of different types of target proteins leads to cellular growth defects, and the mechanism for transporting proteins out of a cell nucleus has the lowest over-expression tolerance.

Vigorous exercise can modulate various parameters associated with improved sleep

Physical exercise has long been prescribed as a way to improve the quality of sleep. But now, researchers from Japan have found that even when exercise causes objectively measured changes in sleep quality, these changes may not be subjectively perceptible.

Hypertension drug market to decrease through 2013 due to generic erosion and few emerging therapies

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in addition to extensive generic erosion, the hypertension drug market will be constrained through 2018 by a pipeline containing very few emerging therapies with novel mechanisms of action. Gilead's darusentan was positioned to be the next emerging therapy with a novel mechanism of action to reach the hypertension market. However, following darusentan's failure to meet its primary endpoint in the recent DORADO-AC Phase III clinical trial, further development of the agent has been terminated.

Obama, Romney and their supporters debate government role in health care

[Bill] Clinton defended the Affordable Care Act that Obama signed into law in 2010, which is now the subject of debate among U.S. Supreme Court justices who are weighing the constitutionality of the legislation's requirement that all people have health insurance.

Read more Medical News

› Verified 8 days ago